NAV2-AS3

Across TCGA pan-cancer cohorts, NAV2-AS3 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated NAV2-AS3 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher NAV2-AS3 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated NAV2-AS3 expression acts as an unfavorable survival marker, although some lineages such as READ and ESCA show a favorable association.

KIRC, KIRP, and ACC are the cancer types where NAV2-AS3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	All	0.532	0.658	.001	61	view →
KIRP	OS	Quartile	All	0.793	0.915	.004	34	view →
ACC	DFS	Tertile	All	0.218	0.657	.021	30	view →
STAD	DFS	Median	II,III,IV	0.565	0.789	.002	27	view →
CESC	DFS	Quartile	II,III,IV	0.324	0.674	.002	24	view →
LUSC	OS	Quartile	III,IV	0.141	0.668	.003	24	view →
READ	OS	Tertile	IV	0.995	0.565	.016	24	view →
LUAD	DFS	Median	All	0.225	0.452	.005	16	view →
ESCA	OS	Quartile	III,IV	0.624	0.319	.021	14	view →
BRCA	DFS	Tertile	IV	0.275	0.799	.005	9	view →
CHOL	OS	Quartile	All	0.296	0.709	.032	3	view →
LIHC	OS	Tertile	All	0.719	0.810	.035	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

NAV2-AS3–KIRC (OS)

Open the KIRC breakdown →